Harvard Apparatus Regenerative Technology (HRGN) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 18, 2026, at the principal executive offices in Holliston, MA, with record date set as April 21, 2026.

• Stockholders will vote on director elections, auditor ratification, executive compensation, and other business.

• Proxy materials are primarily distributed electronically, with options for paper copies upon request.

• 17,580,744 shares of common stock are outstanding and entitled to vote; quorum requires a majority of shares present or represented.

Voting matters and shareholder proposals

• Election of three director nominees for one-year terms expiring at the 2027 annual meeting.

• Ratification of CBIZ CPAs P.C. as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Non-binding advisory vote on executive compensation (say-on-pay).

• Board recommends voting FOR all proposals.

• Procedures for shareholder proposals and director nominations for the 2027 meeting are detailed, with deadlines and requirements.

Board of directors and corporate governance

• Board consists of eight members divided into three classes; seven are independent per Nasdaq standards.

• Directors have diverse backgrounds in healthcare, finance, education, and life sciences.

• Board held 11 meetings in 2025; all directors attended at least 75% of meetings.

• Audit, Compensation, and Governance Committees are fully independent and operate under Board-approved charters.

• Chairman and CEO roles are currently combined but subject to periodic review.